StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Q1 fins today?

<< Previous

Bullboard Posts

Next >>

Comment by Nailbiter2on May 15, 2024 6:18pm

58 Views

Post# 36042170

RE:RE:RE:Q1 fins today?

NewToInvesting7 wrote:
Nailbiter2 wrote: I was told the Q1 fins would be on time but I figure since the stock is still not trading, they can release anytime today including after close.

I'm also waiting for the funky defunct Q4 fins to come out to see if we got our shet together and paid some bills.
I'm usually a very patient man but lately, I've been walking in my back yard to give the oak tree a bite in the bark.

IainCaimbeul wrote: Would not be late would they?

Apologies if I missed it Nailbiter2, but did JHT or IE provide that information (quarterly financials to be filed on time)? I only recall the NRs that stated that they will be filed by 5/31.